The Role of Trop2 Cleavage Products in Prostate Tumorigenesis
Abstract
We have now shown that Trop2 is a new regulator of stem/progenitor activity in the prostate. Trop2 controls self-renewal, proliferation and tissue hyperplasia through two cleavage products (ICD and ECD) generated by RIP. The intracellular domain of Trop2 is released from the membrane and accumulates in the nucleus. Nuclear ICD is found in human prostate cancer but not in the cancer-adjacent benign tissue, suggesting a role for Trop2 cleavage in tumorigenesis. Heightened expression of Trop2 intracellular or extracellular domains are sufficient to initiate precursor lesions to prostate cancer in vivo. Importantly, we demonstrate that Trop2 loss of function cleavage mutants are deficient in inducing self-renewal and tumorigenesis in the prostate. These findings suggest that heightened expression of Trop2 is selected for in epithelial cancers to enhance the stemlike properties of self-renewal and proliferation. Identifying the factors that regulate self-renewal will enhance our understanding of the tumorigenic process and lead to the design of novel cancer therapies.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2013
- Accession Number
- ADA588256
Entities
People
- Tanya Stoyanova
Organizations
- University of California, Los Angeles